Stock A048530 INTRON BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights iNtRON Biotechnology, Inc.

Equities

A048530

KR7048530000

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-09 EDT 		5-day change 1st Jan Change
5,950 KRW -3.09% Intraday chart for iNtRON Biotechnology, Inc. -2.46% -32.23%
03-13 INtRON Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-15 Intron Biotechnology, Inc. Announces New Drug Part Secures A Potent Anti-Cancer Candidate, PHAGERIA®, with Broad Antimicrobial Activity Against ETBF (Enterotoxigenic B. Fragilis), A Harmful Microbe Associated with Colorectal Cancer CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
INtRON Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Intron Biotechnology, Inc. Announces New Drug Part Secures A Potent Anti-Cancer Candidate, PHAGERIA®, with Broad Antimicrobial Activity Against ETBF (Enterotoxigenic B. Fragilis), A Harmful Microbe Associated with Colorectal Cancer
CI
INtRON Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Basilea Pharmaceutica Signs Evaluation License, Option Deal With Korea's iNtRON
MT
INtRON Biotechnology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.
CI
INtRON Biotechnology, Inc.'s Equity Buyback announced on December 2, 2022, has expired with 324,118 shares, representing 0.97% for KRW 2,997.54 million.
CI
INtRON Biotechnology, Inc.'s Equity Buyback announced on December 2, 2022, has expired with
CI
INtRON Biotechnology, Inc.'s Equity Buyback announced on September 20, 2022, has expired with 294,186 shares, representing 0.87% for KRW 2,998.6 million.
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on July 5, 2022.
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on July 5, 2022.
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on July 5, 2022.
CI
Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on July 5, 2022.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A048530 Stock
  4. News iNtRON Biotechnology, Inc.
  5. Highlights